Molecular Targeting Technologies是一家私人控股的生物技術(shù)公司，生產(chǎn)用于疾病治療和診斷的新型放射性藥物。 TDURA（TumorVue®）基于放射性標(biāo)記靶向分子，耐久霉素是MTTI的平臺技術(shù)，具有多種臨床應(yīng)用。它們包括：早期檢測腫瘤對化療的反應(yīng)（一天內(nèi)），心臟毒性，動脈粥樣硬化斑塊，全身炎癥反應(yīng)綜合征（SIRS）和移植排斥反應(yīng)。 Tc-99m，Ga-68，F(xiàn)-18和Cu-64-耐久霉素以及各種熒光類似物正在開發(fā)中。正在開發(fā)的治療分子包括：用于多形性成膠質(zhì)細(xì)胞瘤（GBM）的131I-SapC-DOPS和用于神經(jīng)內(nèi)分泌腫瘤的177Lu-DOTA-X-TATE。這些治療藥物基于統(tǒng)計(jì)數(shù)據(jù)研發(fā)的，F(xiàn)DA正在進(jìn)行I期臨床試驗(yàn)支持。

產(chǎn)品	貨號	規(guī)格
CellVue® Maroon	C-1001	Mini: 0.1mL dye + 10mL diluent Midi: 0.2mL dye + 60mL diluent Maxi: 0.5mL dye + 60mL diluent
CellVue® Claret	C-1002	Mini: 0.1mL dye + 10mL diluent Midi: 0.2mL dye + 60mL diluent
CellVue® Plum	C-1003	Mini: 0.1mL dye + 10mL diluent Midi: 0.2mL dye + 60mL diluent Maxi: 0.5mL dye + 60mL diluent
CellVue® Burgundy	C-1004	Mini: 0.1mL dye + 10mL diluent Midi: 0.2mL dye + 60mL diluent Maxi: 0.5mL dye + 60mL diluent
Molday ION™ DOTA	MI-1001	0.5ML
Molday ION™ C2Azide	MI-1002	1ML
Duramycin-NIR790 conjugate	D-1004	50nmoles/144ugrams
PSVue® 794	P-1001	The PSVue 794 (formerly PSS-794) reagent kit contains components to provide ~ 0.68 mL of a 1 mM solution of PSVue 794 in aqueous solution.
PSVue® 380	P-1002	The PSVue®380 (formerly PSS-380) reagent kit contains components to provide ~ 0.40 mL of a 2 mM solution of PSVue®380 in 50% aqueous ethanol solution.
PSVue® 480	P-1003	The PSVue 480 (formerly PSS-480) reagent kit contains components to provide ~0.5 mL of a 1 mM solution of PSVue 480.
PSVue® Biotin	P-1004	Vial contains 1mg of solid.
CyAL-5 Fluorescent Dye	MF-1001	1mg ，5mg，25mg
Doxorubicin hydrochloride (DOX)	BA-1001	10mg/50mg
Duramycin-LC-Biotin	D-1003	100 ugrams/42.5 nmoles
SANH	CL-1001	10mg/25mg
Estradiol Sepharose 6B	AA-1001	1 ml /10ML
Dexamethasone Sepharose 6B	AA-1004	1ml/10ml

上一篇：Molecular Targeting Technologies產(chǎn)品 PSVue貨號P-1005說明書

下一篇：Molecular Targeting Technologies公司介紹和產(chǎn)品線簡介

返回列表>>

15210359867